This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignee: University of Massachusetts. Active years: 1999-2016.
Location History:
- Worcester, MA (US) (1999)
- Princeton, MA (US) (2007 - 2013)
- Sterling, MA (US) (2015 - 2016)
Company Filing History:
Years Active: 1999-2016
Title: The Innovative Contributions of Stephen J Doxsey
Introduction
Stephen J Doxsey is a prominent inventor based in Princeton, MA (US). He has made significant contributions to the field of cell biology, particularly in understanding cell division and its implications for cancer treatment. With a total of 8 patents, Doxsey's work has garnered attention for its potential applications in medical science.
Latest Patents
Doxsey's latest patents include groundbreaking research on the modulation of midbody derivatives. This patent discusses how the number of midbody derivatives in a cell can be modulated by influencing autophagy induced by NBR1. The methods outlined in this patent could be pivotal in treating cancers or reprogramming cells. Another notable patent is related to a newly identified animal cell structure known as the midbody scar. This structure serves as a remnant of the midbody retained by one daughter cell after cytokinesis and can be utilized as a marker for dividing cells or a cell's replicative age.
Career Highlights
Stephen J Doxsey is affiliated with the University of Massachusetts, where he continues to advance research in cell biology. His innovative work has positioned him as a leading figure in his field, contributing to both academic knowledge and practical applications in medicine.
Collaborations
Doxsey has collaborated with notable colleagues such as Chun-Ting Chen and Tse-Chun Kuo. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
In summary, Stephen J Doxsey's contributions to cell biology through his patents and research are invaluable. His work not only enhances our understanding of cell division but also opens new avenues for cancer treatment and cellular reprogramming.